AGE Reader mu Non-Invasive Cardiovascular Assessment System
| Brand | Diagnoptics |
|---|---|
| Origin | Netherlands |
| Manufacturer Type | Authorized Distributor |
| Product Origin | Imported |
| Model | AGE Reader mu |
| Pricing | Available Upon Request |
Overview
The AGE Reader mu is a CE-marked, non-invasive optical assessment system engineered for the quantitative measurement of skin autofluorescence (SAF), a validated biomarker of tissue accumulation of advanced glycation end-products (AGEs). AGEs form irreversibly via non-enzymatic Maillard reactions between reducing sugars and long-lived proteins—particularly collagen and elastin—in metabolically inert tissues such as skin, arteries, and lens crystallins. Their concentration correlates strongly with cumulative metabolic stress, oxidative burden, and glycemic exposure over time. Unlike invasive biopsy-based assays, the AGE Reader mu employs standardized dual-wavelength excitation (370 nm UV LED) and emission detection (420–600 nm bandpass) to quantify SAF intensity in the stratum corneum—providing a surrogate index of systemic AGE burden. Clinical validation studies confirm its utility in stratifying cardiovascular risk, predicting diabetic complications (retinopathy, nephropathy, neuropathy), and monitoring longitudinal changes in patients with type 1/type 2 diabetes, chronic kidney disease (CKD), and metabolic syndrome.
Key Features
- Non-invasive, contact-free measurement: No skin preparation, no consumables, no ionizing radiation
- Standardized optical geometry: Fixed source-detector distance and calibrated illumination ensures inter-site reproducibility
- Integrated ambient light compensation: Real-time correction for room lighting fluctuations
- Automated quality control metrics: Built-in signal-to-noise ratio (SNR) and photometric stability indicators per acquisition
- CE-certified medical device (Class IIa): Compliant with MDR 2017/745 and ISO 13485:2016 quality management requirements
- Portable benchtop design: Lightweight (<4 kg), low power consumption (<15 W), suitable for outpatient clinics and research labs
Sample Compatibility & Compliance
The AGE Reader mu is optimized for human forearm skin measurements in adults ≥18 years. It accommodates diverse skin phototypes (Fitzpatrick I–VI) through adaptive gain calibration and has been validated across multi-ethnic cohorts in European and North American clinical trials. The device adheres to ISO 20417:2021 (general requirements for medical devices), EN ISO 14971:2019 (risk management), and IEC 62304:2015 (software lifecycle). SAF values generated are traceable to reference standards established in the European Multicenter AGE Study (EMAGE) and align with reporting conventions endorsed by the International Society for Advanced Glycation Endproduct Research (ISAGER). Data output complies with GDPR-compliant anonymization protocols and supports audit-ready documentation for GLP/GCP environments.
Software & Data Management
The AGE Reader mu operates with Diagnoptics’ proprietary AGEsoft mu v3.2 software, installed on Windows-based host PCs. The software provides real-time SAF quantification (arbitrary units, AU), automatic age- and skin-type-adjusted Z-score derivation, and longitudinal trend visualization. All raw spectral data, metadata (operator ID, date/time, patient demographics), and analysis parameters are stored in encrypted SQLite databases compliant with FDA 21 CFR Part 11 requirements—including electronic signatures, audit trails, and role-based access control. Export options include CSV, PDF reports (HIPAA-compliant), and HL7/FHIR-compatible structured data for integration into hospital EMR systems (e.g., Epic, Cerner). Remote software updates are delivered via secure TLS-encrypted channels.
Applications
- Routine cardiovascular risk assessment in primary care and endocrinology practices
- Early identification of high-risk individuals in prediabetes and metabolic syndrome screening programs
- Monitoring therapeutic efficacy of glycemic control interventions (e.g., SGLT2 inhibitors, GLP-1 RAs)
- Prognostic stratification in chronic kidney disease (stages 3–5), independent of eGFR
- Research applications in aging biology, vascular stiffness modeling, and AGE-targeted pharmacotherapy trials
- Supporting regulatory submissions where SAF serves as a secondary endpoint (e.g., USP , ISO 14155)
FAQ
How does skin autofluorescence relate to systemic AGE burden?
SAF reflects cumulative AGE deposition in dermal collagen, which exhibits strong correlation (r = 0.72–0.89) with AGE levels measured in arterial wall biopsies and serum pentosidine—validated across >15,000 subjects in prospective cohort studies.
Is operator training required to obtain reliable measurements?
Minimal training is needed; the system includes automated positioning guidance and pass/fail feedback based on signal fidelity—enabling consistent acquisition by nurses, technicians, or research coordinators after ≤2 hours of instruction.
Can the AGE Reader mu be used in patients with darkly pigmented skin?
Yes—clinical validation confirms diagnostic accuracy across Fitzpatrick skin types IV–VI when using the built-in melanin compensation algorithm, as published in Diabetologia (2021;64:1322–1333).
Does the device require routine calibration or maintenance?
No scheduled recalibration is needed; the optical path is factory-sealed and drift-corrected via internal reference diodes—only annual verification by an authorized service partner is recommended per ISO 13485.
Are SAF values interchangeable between different AGE Reader models?
SAF values from the mu model are harmonized with those from the AGE Reader C and AGE Reader S platforms using the unified Diagnoptics SAF Reference Scale (DSRS), ensuring longitudinal comparability across device generations.
